Federated Hermes, Inc. Emergent Bio Solutions Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 271,752 shares of EBS stock, worth $2.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

271,752

Previous 273,287 0.56%

Holding current value

$2.29 Million

Previous $1.86 Million 21.79%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.72 - $14.77 $8,780 - $22,671	-1,535 Reduced 0.56%	271,752 $2.27 Million
Q2 2024 Aug 08, 2024	BUY	$1.86 - $6.98 $472,365 - $1.77 Million	253,960 Added 1314.02%	273,287 $1.86 Million
Q1 2024 May 14, 2024	SELL	$1.5 - $3.41 $3,151 - $7,164	-2,101 Reduced 9.8%	19,327 $48,000
Q4 2023 Jan 31, 2024	SELL	$1.82 - $3.16 $333,789 - $579,547	-183,401 Reduced 89.54%	21,428 $51,000
Q3 2023 Nov 13, 2023	SELL	$3.17 - $7.91 $147,950 - $369,175	-46,672 Reduced 18.56%	204,829 $696,000
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $3.27 Million - $5.87 Million	-444,230 Reduced 63.85%	251,501 $1.85 Million
Q1 2023 May 08, 2023	BUY	$7.79 - $16.29 $168,972 - $353,346	21,691 Added 3.22%	695,731 $7.21 Million
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $2.98 Million - $5.82 Million	271,342 Added 67.38%	674,040 $7.96 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $7.65 Million - $13.6 Million	380,668 Added 1727.95%	402,698 $8.45 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $7.57 Million - $12 Million	-276,178 Reduced 92.61%	22,030 $684,000
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $10.9 Million - $15.5 Million	297,551 Added 45289.35%	298,208 $12.2 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $4.65 Million - $7.72 Million	-140,415 Reduced 99.53%	657 $29,000
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $214,800 - $283,354	-4,290 Reduced 2.95%	141,072 $7.06 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $5.62 Million - $7.99 Million	-99,328 Reduced 40.59%	145,362 $9.16 Million
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $1.19 Million - $1.73 Million	13,835 Added 5.99%	244,690 $22.7 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $4.01 Million - $5.64 Million	50,628 Added 28.09%	230,855 $20.7 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $3.16 Million - $5.21 Million	38,611 Added 27.26%	180,227 $18.6 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $4.01 Million - $6.6 Million	-73,746 Reduced 34.24%	141,616 $11.2 Million
Q1 2020 May 13, 2020	SELL	$49.34 - $68.76 $2.11 Million - $2.94 Million	-42,798 Reduced 16.58%	215,362 $12.5 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $1.61 Million - $1.86 Million	-31,500 Reduced 10.87%	258,160 $13.9 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $775,784 - $1.09 Million	19,108 Added 7.06%	289,660 $15.1 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $1.34 Million - $1.81 Million	33,611 Added 14.19%	270,552 $13.1 Million
Q1 2019 May 10, 2019	BUY	$48.23 - $66.16 $59,226 - $81,244	1,228 Added 0.52%	236,941 $12 Million
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $904,154 - $1.19 Million	16,253 Added 7.41%	235,713 $14 Million
Q3 2018 Nov 13, 2018	BUY	$52.05 - $66.51 $2.65 Million - $3.39 Million	50,980 Added 30.26%	219,460 $14.4 Million
Q2 2018 Aug 10, 2018	SELL	$48.33 - $55.64 $6.71 Million - $7.73 Million	-138,856 Reduced 45.18%	168,480 $8.51 Million
Q1 2018 May 09, 2018	SELL	$44.44 - $54.39 $8.15 Million - $9.98 Million	-183,505 Reduced 37.39%	307,336 $16.2 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $9.92 Million - $12.5 Million	262,729 Added 115.18%	490,841 $0
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $7.79 Million - $9.23 Million	228,112	228,112 $9.23 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Emergent Bio Solutions Inc. Transaction History